Literature DB >> 11466784

Rapid quality control analysis of (13)C-enriched substrate synthesis by isotope ratio mass spectrometry.

D J Morrison1, B Dodson, T Preston, L T Weaver.   

Abstract

There is a growing interest in the use of (13)C-enriched substrates to investigate metabolic processes in humans. The non-invasive nature of (13)C breath tests makes them attractive to clinicians, particularly because they can be safely used in children. The availability of suitable (13)C-enriched substrates can limit the application of this biotechnology. We have used isotope ratio mass spectrometry to assay the chemical purity and isotopic enrichment of substrates that were synthesised to study gut transit and colonic fermentation. Lactose ureide and lactose [(13)C]ureide were synthesised by acid-catalysed condensation of lactose and urea or (13)C urea, respectively. Glucose ureide and glucose [(13)C]ureide were synthesised by similar methods but required an additional purification step to remove urea of crystallisation. Substrates were analysed by standard analytical techniques and combustion isotope ratio mass spectrometry for carbon and nitrogen content and (13)C-enrichment. Monitoring the C/N ratio proved to be a sensitive assay of chemical purity. Analysis of the percentage composition of C and N (and hence O + H) suggested that lactose ureide crystallises as the dihydrate. It was synthesised with approximately 99% chemical purity and with the theoretical enrichment. Glucose ureide was synthesised with approximately 98% chemical purity but with lower than theoretical enrichment. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11466784     DOI: 10.1002/rcm.341

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  1 in total

1.  Does the biomarker 15N-lactose ureide allow to estimate the site of fermentation of resistant starch?

Authors:  Lieselotte Cloetens; Vicky De Preter; Henriette De Loor; Paul Rutgeerts; Kristin Verbeke
Journal:  Eur J Nutr       Date:  2008-06-16       Impact factor: 5.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.